MSH2 and colorectal carcinoma: Even though the cohort was specifically targeted to dominant hCRC syndromes by the selection of CRC cases ≤55 years and with at least one first-degree relative with CRC, only the well-established genes for hCRC and polyposis (APC, MLH1, MSH2) reached significant enrichment in cases versus controls [65].